CAPITAL MANAGEMENT CORP /VA - ANIKA THERAPEUTICS INC ownership

ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 120 filers reported holding ANIKA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.22 and the average weighting 0.0%.

Quarter-by-quarter ownership
CAPITAL MANAGEMENT CORP /VA ownership history of ANIKA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,569,112
-35.6%
84,225
-17.7%
0.35%
-48.5%
Q3 2022$2,437,000
-60.3%
102,390
-62.8%
0.69%
-54.7%
Q2 2022$6,141,000
+20.9%
275,130
+36.0%
1.52%
+39.8%
Q1 2022$5,079,000
+6.7%
202,258
+52.2%
1.09%
+9.9%
Q4 2021$4,760,000
-5.6%
132,850
+12.1%
0.99%
-10.3%
Q3 2021$5,043,000
+17.3%
118,490
+19.3%
1.10%
+20.7%
Q2 2021$4,299,000
-27.5%
99,305
-31.7%
0.91%
-31.2%
Q1 2021$5,927,000
+40.8%
145,310
+56.2%
1.32%
+15.3%
Q4 2020$4,211,000
+25.5%
93,035
-1.9%
1.15%
+8.9%
Q3 2020$3,356,000
-50.3%
94,830
-47.1%
1.06%
-53.2%
Q2 2020$6,759,000
+151.6%
179,151
+92.8%
2.26%
+129.5%
Q1 2020$2,686,000
+4.2%
92,905
+86.9%
0.98%
+49.6%
Q4 2019$2,578,000
-3.8%
49,712
+1.8%
0.66%
-10.5%
Q3 2019$2,681,000
-7.6%
48,842
-31.7%
0.73%
-8.5%
Q2 2019$2,903,000
-14.3%
71,471
-36.2%
0.80%
-13.9%
Q1 2019$3,387,000
-1.0%
111,996
+10.0%
0.93%
-12.3%
Q4 2018$3,422,000
+1.4%
101,819
+27.2%
1.06%
+23.2%
Q3 2018$3,375,000
-18.1%
80,025
-37.8%
0.86%
-22.2%
Q2 2018$4,120,000
+17.7%
128,737
+82.8%
1.11%
+17.6%
Q1 2018$3,501,000
+6.3%
70,418
+15.3%
0.94%
+5.4%
Q4 2017$3,293,000
-7.5%
61,085
-0.5%
0.89%
-12.1%
Q3 2017$3,560,000
+18.2%
61,375
+0.6%
1.02%
+13.1%
Q2 2017$3,011,000
-52.4%
61,030
-58.1%
0.90%
-54.1%
Q1 2017$6,322,000
-17.7%
145,540
-7.2%
1.96%
-23.6%
Q4 2016$7,681,000
+17.2%
156,885
+14.6%
2.56%
+6.0%
Q3 2016$6,553,000
-34.0%
136,940
-26.0%
2.42%
-37.1%
Q2 2016$9,924,000
+4.8%
184,985
-12.6%
3.85%
+5.1%
Q1 2016$9,465,000
+163.2%
211,660
+124.6%
3.66%
+168.3%
Q4 2015$3,596,000
+32.4%
94,230
+10.4%
1.36%
+25.1%
Q3 2015$2,716,000
+6.5%
85,330
+10.5%
1.09%
+23.0%
Q2 2015$2,551,000
-7.7%
77,220
+15.0%
0.89%
-5.2%
Q1 2015$2,764,000
+1.4%
67,125
+0.4%
0.94%
+11.3%
Q4 2014$2,725,000
+11.2%
66,880
+0.0%
0.84%
+3.6%
Q3 2014$2,451,000
+6.3%
66,860
+34.4%
0.81%
+8.9%
Q2 2014$2,306,000
+14.1%
49,765
+1.2%
0.74%
+8.1%
Q1 2014$2,021,000
+15.8%
49,180
-32.7%
0.69%
+2.2%
Q3 2013$1,745,00073,0500.67%
Other shareholders
ANIKA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Trigran Investments, Inc. 954,799$23,975,0002.44%
CAPITAL MANAGEMENT CORP /VA 202,258$5,079,0001.09%
Riverwater Partners LLC 12,370$311,0000.51%
DIKER MANAGEMENT LLC 21,835$548,0000.44%
Ranger Investment Management 136,381$3,425,0000.22%
CHATHAM CAPITAL GROUP, INC. 23,757$597,0000.12%
Teton Advisors, Inc. 22,000$552,0000.10%
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 1,412,259$35,462,0000.09%
Intercontinental Wealth Advisors, LLC 14,257$358,0000.08%
FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ 385,528$9,681,0000.06%
View complete list of ANIKA THERAPEUTICS INC shareholders